R0404

Ramipril

synthetic (organic), ≥98% (HPLC), Angiotensin converting enzyme (ACE) inhibitor., powder

• Synonym(s): Tritace, [2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid
• Empirical Formula (Hill Notation): C₂₃H₃₂N₂O₅
• CAS Number: 87333-19-5
• Molecular Weight: 416.51
• UNSPSC Code: 12352200
• PubChem Substance ID: 24724586
• NACRES: NA.77
• MDL number: MFCD00865775
• Assay: ≥98% (HPLC)
• Form: powder

Properties

• Product Name: Ramipril, ≥98% (HPLC)
• biological source: synthetic (organic)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white
• solubility: DMSO: ~18 mg/mL
• originator: Sanofi Aventis
• storage temp.: 2-8°C
• SMILES string: O=C(N1[C@](CCC2)([H])[C@]2([H])C[C@H]1C(O)=O)[C@H](C)N[C@H](C(OCC)=O)CCC3=CC=CC=C3
• InChI: 1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1
• InChI key: HDACQVRGBOVJII-JBDAPHQKSA-N
• Gene Information: human ... ACE(1636)

Description

Biochem/physiol Actions

Angiotensin converting enzyme (ACE) inhibitor.

Features and Benefits

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• pictograms: GHS08
• signalword: Danger
• hcodes: H360FD
• pcodes: P201 - P202 - P280 - P308 + P313 - P405 - P501
• Hazard Classifications: Repr. 1B
• Storage Class: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• wgk: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: Eyeshields, Gloves, type N95 (US)